AlphaStocks

AZN vs PPLI

ASTRAZENECA PLC vs People Inc — Side-by-Side Stock Comparison

AZN

ASTRAZENECA PLC

8.4

Strong Buy

$174.90

PPLI

People Inc

2.7

Avoid

$42.71

AZN vs PPLI: Which is the Better Investment?

ASTRAZENECA PLC (AZN) scores 8.4/10 while People Inc (PPLI) scores 2.7/10 on AlphaStocks' composite model. ASTRAZENECA PLC has the higher composite rating of Strong Buy.

This comparison is algorithmically generated and is not financial advice.

MetricAZNPPLI
Scores & Fundamentals
Composite Score8.4/102.7/10
RatingStrong BuyAvoid
Price$174.90$42.71
P/E Ratio26.7
ROE21.9%-2.0%
Market Cap$273B$3B
Fair Value$192.63
Dividend Yield1.8%
Sector Rank#3 of 1124#1048 of 1124
Model Verdicts
PiotroskiStrongNeutral
BuffettStrongCaution
GrahamCautionNeutral
LynchNeutralLimited Data
GreenblattNeutralCaution
View full AZNanalysis →View full PPLIanalysis →
Compare any two stocks →

AZN vs PPLI: Which Stock Scores Higher?

ASTRAZENECA PLC (AZN) and People Inc (PPLI) are among the most compared stocks in the S&P 500. AZN currently leads with a composite score of 8.4/10 (Strong Buy) compared to PPLI's 2.7/10 (Avoid).

The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.

This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer